No excess risk of breast cancer among female users of systemic glucocorticoids

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 4, 2005, Pages 1022-1023

  Sørensen, Henrik Toft ^a   Mellemkjær, Lene ^b   Skriver, Mette Vinther ^a   Lash, Timothy L ^c   Olsen, Jørgen H ^b   Baron, John A ^d  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^c BOSTON UNIVERSITY   (United States)

^d DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETAMETHASONE; CYCLOSPORIN; CYTOSTATIC AGENT; FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PREDNISOLONE; PREDNISONE; TACROLIMUS; TRIAMCINOLONE;

ADOLESCENT; ADULT; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT;

BREAST NEOPLASMS; DENMARK; FEMALE; GLUCOCORTICOIDS; HUMANS; MIDDLE AGED; NO-OBSERVED-ADVERSE-EFFECT LEVEL; REGISTRIES; RISK FACTORS;

EID: 16444365481     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-04-0488     Document Type: Article

References (9)

1. Michels KB, Solomon CG, HU FB, Hankinson SE, Colditz GA, Manson JE. Type 2 diabetes and subsequent incidence of breast cancer in the nurses' health study. Diabetes Care 2003;26:1752-8.
2. Saydah SH, Loria CM, Eberhardt MS, Brancati FL. Abnormal tolerance and the risk of cancer death in the United States. Am J Epidemiol 2003;157:1092-100.
3. Mink PJ, Shahar E, Rosamond WD, Alberg AJ, Folsom AR. Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol 2002;156:349-52.
4. Dawson SI. Long-term risk of malignant neoplasm associated with gestational glucose intolerance. Cancer 2004;100:149-55.
5. Pollak M. Insulin-like growth factor physiology and cancer risk. Eur J Cancer 2000;36:1224-8.
6. Giovannucci E. Insulin, Insulin-Like Growth Factors and Colon Cancer: A Review of the Evidence. J Nutr 2001;131:3109-20S.
7. Baron JA, Weiderpass E, Newcomb PA, et al. Metabolic disorders and breast cancer risk (United States). Cancer Causes Control 2001;12:875-80.
8. Schàcke H, Döcke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 2002;96:23-43.
9. Sørensen HT, Mellemkjeer L, Nielsen GL, Baron JA, Olsen JH, Karagas MR. Skin cancers and non-Hodgkin lymphoma among users of glucocorticoids: a population-based cohort study. J Natl Cancer Inst 2004;96:709.